Skip to main content
. 2021 Jun 1;67(2):fmab037. doi: 10.1093/tropej/fmab037

Table 4.

Characteristics of COVID19 patients with AKI Stage 3

Characteristics Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9
Age (months) 18 132 156 120 24 144 9 36 132
Sex M F M M F F M F M
Hb (g/dl) 10 8.3 5.7 11.5 6.2 6.9 7.4 5.1 6
TLC (/mm3) 2400 19 000 97 800 9400 20 700 42 000 16 700 118 000 750
Platelet (/109/l) 20 000 98 000 31 000 70 000 67 000 78 000 527 000 8000 6000
BS. Cr (mg/dl) 0.33 0.48 0.56 0.45 0.32 0.50 0.31 0.28 0.48
PS. Cr (mg/dl) 3.4 1.5 2.8 1.83 3.05 3.92 0.93 0.97 2.5
Shock Yes Yes Yes Yes Yes Yes No No Yes
Vasopressor Yes Yes Yes Yes Yes Yes No No Yes
Ventilation Yes Yes Yes Yes Yes No No No Yes
Co-morbidity Yesa Yesb Yesc Yesd Yese Yesf Yesg Yesh Yesi
MIS-C No Yes Yes Yes No No No No Yes
Outcome Death Death Death Death Death Death Disch Disch Disch

Dich., discharge; MIS-C, multisystem inflammatory syndrome in children; BS. Cr, baseline serum creatinine; PS.Cr, peak serum creatinine; Hb, hemoglobin; TLC, total leukocyte count.

a

Severe acute malnutrition with sepsis.

b

Toxic shock syndrome.

c

B cell ALL/tumor lysis syndrome/Invasive pulmonary aspergillosis.

d

Severe dengue with shock/MODS.

e

Tubercular meningitis (Stage 3).

f

Liver abscess/pneumonia/sepsis/MODS.

g

Abdominal cystic mass/sepsis.

h

B cell ALL.

i

Severe aplastic anemia/hepatitis B/neutropenic enterocolitis/secondary HLH.